2 Reasons This Stock Could Outperform in 2023

2 Reasons This Stock Could Outperform in 2023

Biotech giant Gilead Sciences (NASDAQ: GILD) is a member of this elite club, having seen its shares rise by 15% year to date. Let's consider two reasons why Gilead Sciences is worth serious consideration heading into the new year. Gilead Sciences' most important unit by some margin remains its HIV business.